21 – 29 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- next »
- 2016
-
Mark
Paradoxical role of hmgb1 in pancreatic cancer : Tumor suppressor or tumor promoter?
(
- Contribution to journal › Scientific review
-
Mark
Comprehensive analysis of histone related modifications of formaldehyde fixed paraffin embedded and fresh frozen pancreatic tumor xenografts using LC-MS/MS
(
- Contribution to journal › Article
- 2015
-
Mark
Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer.
(
- Contribution to journal › Article
-
Mark
In vitro cytotoxicity evaluation of HDAC inhibitor Apicidin in pancreatic carcinoma cells subsequent time and dose dependent treatment.
(
- Contribution to journal › Article
-
Mark
Protein deep sequencing applied to biobank samples from patients with pancreatic cancer.
(
- Contribution to journal › Article
-
Mark
Radioimmunotherapy-a potential novel tool for pancreatic cancer therapy?
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Apicidin Sensitizes Pancreatic Cancer Cells to Gemcitabine by Epigenetically Regulating MUC4 Expression.
(
- Contribution to journal › Article
-
Mark
Analysis of MUC4 Expression in Human Pancreatic Cancer Xenografts in Immunodeficient Mice.
(
- Contribution to journal › Article
- 2013
-
Mark
Comparison of MUC4 expression in primary pancreatic cancer and paired lymph node metastases.
(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- next »